Early effects of insulin-like growth factor-1 in activated human T lymphocytes
This study evaluates the effects of insulin-like growth factor (IGF)-1 receptor (IGF-1R) down-regulation in stimulated T lymphocytes by investigating the expression of early activation proteins CD69, CD25, and interleukin (IL)-2. We found that IGF-1 does not modify CD69 expression but increases tran...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2001
|
| Acceso en línea: | Registro en Scopus Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 12644caa a22014177a 4500 | ||
|---|---|---|---|
| 001 | PAPER-20591 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205200.0 | ||
| 008 | 190411s2001 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0034891575 | |
| 024 | 7 | |2 cas |a Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD69 antigen; Immediate-Early Proteins; Insulin-Like Growth Factor I, 67763-96-6; Interleukin-2; Mitogen-Activated Protein Kinases, EC 2.7.1.37; Receptor, IGF Type 1, EC 2.7.1.112; Receptors, Interleukin-2; RNA, Messenger | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a JLBIE | ||
| 100 | 1 | |a Brocardo, M.G. | |
| 245 | 1 | 0 | |a Early effects of insulin-like growth factor-1 in activated human T lymphocytes |
| 260 | |c 2001 | ||
| 270 | 1 | 0 | |m Roldán, A.; Inst. de Biologia y Medicina Exp., Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina; email: aroldan@dna.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Florini, J.R., Ewton, D.Z., Falen, S.L., Van Wik, J.J., Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins (1986) Am. J. Physiol., 250, pp. C771-C778 | ||
| 504 | |a Lower, W.L., Lasky S.R., Jr., LeRoith, D., Roberts C.T., Jr., Distribution and regulation of rat insulin-like growth factor 1 messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver (1988) Mol. Endocrinol., 2, pp. 528-535 | ||
| 504 | |a Roldán, A., Charreau, E.H., Schillaci, R., Eugui, E.M., Allison, A.C., Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin (1989) Immunol. Lett., 20, pp. 5-8 | ||
| 504 | |a Johnson, E.W., Jones, L.A., Kozak, R.W., Expression and function of insulin-like growth factor receptors on anti-CD-3 activated human T lymphocytes (1992) J. Immunol., 148, pp. 63-71 | ||
| 504 | |a Schillaci, R., Brocardo, M.G., Galeano, A., Roldán, A., Down-regulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation (1998) Cell. Immunol., 183, pp. 157-161 | ||
| 504 | |a Thies, R.S., Webster, N.J., McClain, D.A., A domain of the insulin receptor required for endocytosis in rat fibroblast (1990) J. Biol. Chem., 265, pp. 10132-10137 | ||
| 504 | |a Vieira, A.V., Lamaze, C., Schmid, S.L., Control of EGF receptor signaling by clathrin-mediated endocytosis (1996) Science, 274, pp. 2086-2089 | ||
| 504 | |a Chow, J.C., Condorelli, G., Smith, R.J., Insulin-like growth factor-1 receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway (1998) J. Biol. Chem., 273, pp. 4672-4680 | ||
| 504 | |a Wiley, H.S., Herbst, J.J., Walsh, B.J., Leauffenburger, D.A., Rosenfeld, M.G., Gill, G.N., The role of tyrosine kinase activity in endocytosis, compartimentation, and down-regulation of the epidermal growth factor receptor (1991) J. Biol. Chem., 266, pp. 11083-11094 | ||
| 504 | |a Cantrell, D., T cell antigen receptor signal transduction pathways (1996) Annu. Rev. Immunol., 14, pp. 259-274 | ||
| 504 | |a Ulman, K.S., Northrop, J.P., Verweij, C.L., Crabtree, G.R., Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function (1990) Annu. Rev. Immunol., 8, pp. 421-452 | ||
| 504 | |a López-Cabrera, M., Santis, A.G., Fernández-Ruiz, E., Blacher, R., Esch, F., Sanchez-Mateos, P., Sanchez-Madrid, F., Molecular cloning, expression, and chromosomal localization of human earliest lymphocyte activation antigen AIM/CD69, a new member of the c-type animal lectin superfamily of signal-transmitting receptors (1993) J. Exp. Med., 178, pp. 537-547 | ||
| 504 | |a Smith, K.A., Cantrell, D.A., Interleukin-2 regulates its own receptors (1985) Proc. Natl. Acad. Sci. USA, 82, pp. 864-868 | ||
| 504 | |a Zhou, L., Ritchie, D., Wang, E.Y., Barbone, A.G., Argentieri, D., Lau, C.Y., Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A (1994) J. Immunol., 153, pp. 5026-5037 | ||
| 504 | |a Swoli, D., Brantsing, C., Matejka, G., Ohlsson, C., Cortisol decreases IGF-1 mRNA levels in human osteoblast-like cells (1996) J. Endocrinol., 149, pp. 397-403 | ||
| 504 | |a Leonard, W.J., Depper, J.M., Crabtree, G.R., Rudikoff, S., Pumphrey, J., Robb, R.J., Kronke, M., Greene, W.C., Molecular cloning and expression of cDNA for the human interleukin-2 receptor (1984) Nature, 311, pp. 626-631 | ||
| 504 | |a Schillaci, R., Brocardo, M.G., Roldán, A., Co-operative effect between insulin-like growth factor-1 and interleukin-2 on DNA synthesis and interleukin-2 receptor-α chain expression in human lymphocytes (1995) Immunol. Cell Biol., 73, pp. 340-345 | ||
| 504 | |a Wiskocil, R., Weiss, A., Imboden, J., Kamin-Lewis, R., Stobo, J., Activation of a human T cell line: A two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and γ-interferon genes (1985) J. Immunol., 134, pp. 1599-1603 | ||
| 504 | |a Calvo, C.-F., Chavanel, G., Senik, A., Substance P enhances IL-2 expression in activated human T cells (1992) J. Immunol., 148, pp. 3498-3504 | ||
| 504 | |a Jendraschak, E., Kaminski, W.E., Hessel, F., Kiefl, R., Von Schacky, C., Growth factor mRNA profiles in unstimulated human mononuclear cells: Identification of genes which are constitutively and variably expressed (1993) Biochem. Biophys. Res. Commun., 196, pp. 25-31 | ||
| 504 | |a Gerez, L., Arad, G., Efrat, S., Ketzinel, M., Kaempfer, R., Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts (1995) J. Biol. Chem., 270, pp. 19569-19575 | ||
| 504 | |a Kooijamn, R., Rijkers, G.T., Zegers, B.J.M., IGF-1 potentiates interleukin-2 production in human peripheral T cells (1996) J. Endocrinol., 149, pp. 351-356 | ||
| 504 | |a Schillaci, R., Ribaudo, C.M., Rondinone, C.M., Roldán, A., Role of insulin-like growth factor-1 on the kinetics of human lymphocyte stimulation in serum-free culture medium (1994) Immunol. Cell. Biol., 72, pp. 300-305 | ||
| 504 | |a Baxter, J.B., Blalock, J.E., Weigent, D.A., Characterization of immunoreactive insulin-like growth factor-1 from leukocytes and its regulation by growth hormone (1991) Endocrinology, 129, pp. 1727-1734 | ||
| 504 | |a Arkins, S., Rebeiz, N., Biragyn, A., Reese, D.L., Kelly, K.W., Murine macrophages express abundant IGF-1 class 1 Ea and Eb transcripts (1993) Endocrinology, 133, pp. 2334-2343 | ||
| 504 | |a Kooijman, R., Hooghe-Peters, E., Hooghe, R., Prolactin, growth hormone, and insulin-like growth factor-1 in the immune system (1996) Adv. Immunol., 63, pp. 377-454 | ||
| 504 | |a Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., LeRoith, D., Normal growth and development in the absence of hepatic insulin-like growth factor-1 (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 7324-7329 | ||
| 504 | |a Nguyen, B.-Y., Clerici, M., Venzon, D.J., Bauza, S., Murphy, W.J., Longo, D.L., Baseler, M., Yarchoan, R., Pilot study of the immunologic effects of recombinant human growth factors in HIV-infected patients (1998) AIDS, 12, pp. 895-904 | ||
| 504 | |a Thiessen, J.-P., Ketelslegers, J.-M., Underwood, L.E., Nutritional regulation of insulin-like growth factors (1994) Endocr. Rev., 15, pp. 80-101 | ||
| 504 | |a Soliman, A.T., Hassan, A.E.I., Aref, M.K., Hintz, R.L., Rosenfeld, R.G., Rogol, A.D., Serum insulin-like-growth factor I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation (1986) Pedriatr. Res., 20, pp. 1122-1130 | ||
| 504 | |a Johann-Liang, R., O'Neill, L., Cervia, J., Haller, I., Giunta, Y., Licholai, T., Noel, G.J., Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus (2000) AIDS, 14, pp. 683-690 | ||
| 504 | |a Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., Hamuro, J., Structure and expression of cloned cDNA for human interleukin-2 (1983) Nature, 302, pp. 305-310 | ||
| 504 | |a Cosman, D., Cerriti, D.P., Larsen, A., Cloning sequence and expression of human inteleukin-2 receptor (1984) Nature, 312, pp. 768-777 | ||
| 504 | |a Tokunaga, K., Nakamura, Y., Sakata, K., Ohkubo, M., Sawada, K., Sakiyama, S., Enhanced expression of glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers (1987) Cancer Res., 47, pp. 5616-5619 | ||
| 504 | |a Rotwein, P., Two insulin-like growth factor I messenger RNAs are expressed in human liver (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 77-81 | ||
| 520 | 3 | |a This study evaluates the effects of insulin-like growth factor (IGF)-1 receptor (IGF-1R) down-regulation in stimulated T lymphocytes by investigating the expression of early activation proteins CD69, CD25, and interleukin (IL)-2. We found that IGF-1 does not modify CD69 expression but increases transcription and protein synthesis of CD25 and IL-2. The lowest level of IGF-1R detected after 15 min of activation suggested that the effects of IGF-1 occur at the initiation of cell activation. The activation of IGF-1R was confirmed by IGF-1R phosphorylation and increased phosphorylation of microtubule-associated protein kinase. We also detected the alternative IGF-1 transcripts Ea, with paracrine/autocrine regulation, and Eb, with endocrine regulation, in Jurkat cells and in quiescent T lymphocytes, and we detected IGF-1 protein in the culture medium after stimulation. These data suggest that the proliferative effects of IGF-1 on T lymphocytes include both autocrine/paracrine and endocrine processes. |l eng | |
| 593 | |a Inst. de Biologia y Medicina Exp., Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CD25 |
| 690 | 1 | 0 | |a IGF-1 MRNA |
| 690 | 1 | 0 | |a IGF-1 RECEPTOR |
| 690 | 1 | 0 | |a IL-2 |
| 690 | 1 | 0 | |a MAPK |
| 690 | 1 | 0 | |a CD69 ANTIGEN |
| 690 | 1 | 0 | |a INTERLEUKIN 2 |
| 690 | 1 | 0 | |a INTERLEUKIN 2 RECEPTOR |
| 690 | 1 | 0 | |a MICROTUBULE ASSOCIATED PROTEIN |
| 690 | 1 | 0 | |a PROTEIN KINASE (CALCIUM,CALMODULIN) |
| 690 | 1 | 0 | |a SOMATOMEDIN C |
| 690 | 1 | 0 | |a SOMATOMEDIN C RECEPTOR |
| 690 | 1 | 0 | |a TRANSCRIPTION FACTOR |
| 690 | 1 | 0 | |a TRANSCRIPTION FACTOR EA |
| 690 | 1 | 0 | |a TRANSCRIPTION FACTOR EB |
| 690 | 1 | 0 | |a UNCLASSIFIED DRUG |
| 690 | 1 | 0 | |a ANTIGEN EXPRESSION |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a AUTOCRINE EFFECT |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a IMMUNOSTIMULATION |
| 690 | 1 | 0 | |a INSULIN LIKE ACTIVITY |
| 690 | 1 | 0 | |a LEUKEMIA CELL LINE |
| 690 | 1 | 0 | |a MICROTUBULE ASSEMBLY |
| 690 | 1 | 0 | |a PARACRINE SIGNALING |
| 690 | 1 | 0 | |a PATHOPHYSIOLOGY |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN EXPRESSION |
| 690 | 1 | 0 | |a PROTEIN MODIFICATION |
| 690 | 1 | 0 | |a PROTEIN PHOSPHORYLATION |
| 690 | 1 | 0 | |a PROTEIN SYNTHESIS |
| 690 | 1 | 0 | |a RECEPTOR DOWN REGULATION |
| 690 | 1 | 0 | |a T LYMPHOCYTE ACTIVATION |
| 690 | 1 | 0 | |a TRANSCRIPTION REGULATION |
| 690 | 1 | 0 | |a ANTIGENS, CD |
| 690 | 1 | 0 | |a ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE |
| 690 | 1 | 0 | |a DOWN-REGULATION |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a IMMEDIATE-EARLY PROTEINS |
| 690 | 1 | 0 | |a INSULIN-LIKE GROWTH FACTOR I |
| 690 | 1 | 0 | |a INTERLEUKIN-2 |
| 690 | 1 | 0 | |a JURKAT CELLS |
| 690 | 1 | 0 | |a KINETICS |
| 690 | 1 | 0 | |a LYMPHOCYTE ACTIVATION |
| 690 | 1 | 0 | |a MITOGEN-ACTIVATED PROTEIN KINASES |
| 690 | 1 | 0 | |a RECEPTOR, IGF TYPE 1 |
| 690 | 1 | 0 | |a RECEPTORS, INTERLEUKIN-2 |
| 690 | 1 | 0 | |a RNA, MESSENGER |
| 690 | 1 | 0 | |a T-LYMPHOCYTES |
| 690 | 1 | 0 | |a TRANSCRIPTION, GENETIC |
| 700 | 1 | |a Schillaci, R. | |
| 700 | 1 | |a Galeano, A. | |
| 700 | 1 | |a Radrizzani, M. | |
| 700 | 1 | |a White, V. | |
| 700 | 1 | |a González Guerrico, A. | |
| 700 | 1 | |a Santa-Coloma, T.A. | |
| 700 | 1 | |a Roldán, A. | |
| 773 | 0 | |d 2001 |g v. 70 |h pp. 297-305 |k n. 2 |p J. Leukocyte Biol. |x 07415400 |t Journal of Leukocyte Biology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034891575&partnerID=40&md5=75d7d59ca788f8a2e61579907b434447 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_07415400_v70_n2_p297_Brocardo |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07415400_v70_n2_p297_Brocardo |y Registro en la Biblioteca Digital |
| 961 | |a paper_07415400_v70_n2_p297_Brocardo |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 81544 | ||